Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

NR5A2 + LRH1 anticorps (AA 182-291)

NR5A2 Reactivité: Humain WB, ELISA, IHC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7161911
  • Antigène Voir toutes NR5A2 + LRH1 (NR5A2) Anticorps
    NR5A2 + LRH1 (NR5A2) (Nuclear Receptor Subfamily 5, Group A, Member 2 (NR5A2))
    Épitope
    • 7
    • 5
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 182-291
    Reactivité
    • 46
    • 22
    • 19
    • 8
    • 7
    • 6
    • 6
    • 5
    • 5
    • 5
    • 5
    • 3
    • 2
    • 1
    • 1
    Humain
    Hôte
    • 43
    • 5
    • 2
    Lapin
    Clonalité
    • 45
    • 5
    Polyclonal
    Conjugué
    • 34
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp NR5A2 + LRH1 est non-conjugé
    Application
    • 34
    • 16
    • 12
    • 6
    • 3
    • 3
    • 2
    • 2
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
     Réactivité croisée
    Humain, Souris
    Purification
    >95%, Protein G purified
    Immunogène
    Recombinant Human Nuclear receptor subfamily 5 group A member 2 protein (182-291AA)
    Isotype
    IgG
    Top Product
    Discover our top product NR5A2 Anticorps primaire
  • Indications d'application
    Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    NR5A2 + LRH1 (NR5A2) (Nuclear Receptor Subfamily 5, Group A, Member 2 (NR5A2))
    Autre désignation
    NR5A2 (NR5A2 Produits)
    Synonymes
    anticorps xff1rashort, anticorps NR5A2, anticorps b1f, anticorps b1f2, anticorps cpf, anticorps ff1r, anticorps ftf, anticorps ftz-f1, anticorps ftz-f1beta, anticorps hb1f, anticorps hb1f-2, anticorps lrh-1, anticorps lrh1, anticorps xff1ra, anticorps B1F, anticorps B1F2, anticorps CPF, anticorps FTF, anticorps FTZ-F1, anticorps FTZ-F1beta, anticorps LRH-1, anticorps LRH1, anticorps hB1F-2, anticorps xFF1rB, anticorps AU020803, anticorps D1Ertd308e, anticorps Ftf, anticorps UF2-H3B, anticorps Lrh-1, anticorps nuclear receptor subfamily 5 group A member 2 S homeolog, anticorps nuclear receptor subfamily 5 group A member 2, anticorps nuclear receptor subfamily 5 group A member 2 L homeolog, anticorps nuclear receptor subfamily 5, group A, member 2, anticorps nr5a2.S, anticorps NR5A2, anticorps nr5a2, anticorps nr5a2.L, anticorps Nr5a2
    Sujet

    Background: Binds to the sequence element 5\\\'-AACGACCGACCTTGAG-3\\\' of the enhancer II of hepatitis B virus genes, a critical cis-element of their expression and regulation. May be responsible for the liver-specific activity of enhancer II, probably in combination with other hepatocyte transcription factors. Key regulator of cholesterol 7-alpha-hydroxylase gene (CYP7A) expression in liver. May also contribute to the regulation of pancreas-specific genes and play important roles in embryonic development.

    Aliases: Alpha-1-fetoprotein transcription factor antibody, B1-binding factor antibody, B1F antibody, B1F2 antibody, CPF antibody, CYP7A promoter-binding factor antibody, FTF antibody, FTZ F1 antibody, FTZ F1beta antibody, FTZ-F1 antibody, FTZ-F1beta antibody, hB1F 2 antibody, hB1F antibody, hB1F-2 antibody, Hepatocytic transcription factor antibody, Liver receptor homolog 1 antibody, LRH-1 antibody, LRH1 antibody, Nr5a2 antibody, NR5A2_HUMAN antibody, Nuclear receptor subfamily 5 group A member 2 antibody

    UniProt
    O00482
    Pathways
    Nuclear Receptor Transcription Pathway, Steroid Hormone Mediated Signaling Pathway
Vous êtes ici: